Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)
NCT01849770
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
75
Enrollment
OTHER
Sponsor class
Conditions
Sporadic Amyotrophic Lateral Sclerosis
Interventions
DRUG:
Mexiletine
DRUG:
Placebo
Sponsor
University of Washington